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Abstract
 
Human natural killer (NK) T cells are unique T lymphocytes that express an invariant T cell
receptor (TCR) V
 
 
 
24-V
 
 
 
11 and have been implicated to play a role in various diseases. A
subset of NKT cells express CD4 and hence are potential targets for human immunodeficiency
virus (HIV)-1 infection. We demonstrate that both resting and activated human V
 
 
 
24
 
 
 
 T cells
express high levels of the HIV-1 coreceptors CCR5 and Bonzo (CXCR6), but low levels of
CCR7, as compared with conventional T cells. Remarkably NKT cells activated with 
 
 
 
-galac-
tosylceramide (
 
 
 
-GalCer)-pulsed dendritic cells were profoundly more susceptible to infection
with R5-tropic, but not X4-tropic, strains of HIV-1, compared with conventional CD4
 
 
 
 T
cells. Furthermore, resting CD4
 
 
 
 NKT cells were also more susceptible to infection. After ini-
tial infection, HIV-1 rapidly replicated and depleted the CD4
 
 
 
 subset of NKT cells. In addi-
tion, peripheral blood NKT cells were markedly and selectively depleted in HIV-1 infected in-
dividuals. Although the mechanisms of this decline are not clear, low numbers or absence of
NKT cells may affect the course of HIV-1 infection. Taken together, our findings indicate that
CD4
 
 
 
 NKT cells are directly targeted by HIV-1 and may have a potential role during viral
transmission and spread in vivo.
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Introduction
 
NKT cells are a distinct subset of T lymphocytes with
highly conserved TCR in both humans and mice (1–3).
Human NKT cells express a monoclonal TCR consisting
of an invariant V
 
 
 
24-J
 
 
 
18 chain preferentially paired with
a V
 
 
 
11 chain (4–7). NKT cells also share some phenotypic
similarities with classical NK cells, such as the coexpression
of C-type lectin NKRP-1A (CD161) (7). However, a sub-
set of conventional T cells also expresses CD161 and there-
fore, the most reliable marker of NKT cells in humans is
their invariant TCR (8). NKT cells are either CD4
 
 
 
(
 
 
 
30–60%) or CD4
 
 
 
CD8
 
 
 
 with respect to their corecep-
tor expression (9, 10). Phenotypically, NKT cells are also
defined by constitutive expression of the memory marker
CD45RO, both in adults and in neonates (11–13). This
effector/memory phenotype of NKT cells suggests
chronic stimulation by activating self-antigens.
The NKT TCR is specific for glycolipid antigens pre-
sented by the nonpolymorphic MHC class I–like molecule
CD1d (1); however, the natural antigens that activate NKT
cells in the context of CD1d remain unknown. The gly-
cosphingolipid 
 
 
 
-galactosylceramide (
 
 
 
-GalCer), which is
derived from a marine sponge, is the only known antigen
that can bind to CD1d and activate all NKT cells express-
ing the invariant TCR (14–16). Activation of NKT cells in
this manner results in the rapid secretion of large amounts
of cytokines such as IFN-
 
 
 
 and IL-4 (17–20).
In mice NKT cells have been implicated in protective
immune responses against the pathogens 
 
Borrelia burgdorferi
 
(21), 
 
Leishmania major
 
 (22), and diabetogenic encephalomyo-
carditis virus (23). However, it is not clear how NKT cells
mediate their protective function during infections and
whether they play a role against a wider range of patho-
gens, which may include HIV-1 (24, 25).
HIV-1 entry into target cells requires cellular expression
of chemokine receptors, in conjunction with CD4 (26).
CCR5 is the major coreceptor for R5 strains (R5-tropic)
of HIV-1 and most SIV strains, while CXCR4 allows entry
of X4 strains (X4-tropic) (26). Naive and memory subsets
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of conventional CD4
 
 
 
 T cells differ in their expression of
chemokine receptors (27). CXCR4 is predominantly ex-
pressed on the resting naive subset of T cells, whereas
CCR5 is almost exclusively expressed on the activated or
memory subset of human T cells (28). Therefore, only
CD4
 
 
 
 memory T cells are susceptible to infection with
R5-tropic viruses, whereas X4-tropic viruses can enter into
both naive and memory subsets (29–31). During viral
transmission and early in the course of disease R5-tropic
viruses predominate. Thus, memory CD4
 
 
 
 T cells are se-
lectively infected and lost in HIV-1 infected individuals
during the early stages of the infection (32).
Expression of the HIV-1 receptor CD4 on a subset of
human NKT cells as well as their effector/memory pheno-
type under physiological conditions prompted us to inves-
tigate whether these cells are targets for HIV-1 infection.
Herein, we report that human NKT cells express very high
levels of the HIV-1 or SIV coreceptors CCR5 and
CXCR6, and that CD4
 
 
 
 NKT cells are highly susceptible
to infection with R5-tropic HIV-1 strains. We further
demonstrate profoundly reduced numbers of NKT cells
and a selective depletion of the CD4
 
 
 
 NKT cell subset in
HIV-infected adults. These findings suggest a possible role
for NKT cells during the establishment of HIV-1 infection
and as a reservoir for rapid viral spread.
 
Materials and Methods
 
Preparation of Primary Human T Cells and Dendritic Cells.
 
PBMC were separated from buffy coats of healthy donors
through Ficoll-Hypaque (Amersham Pharmacia Biotech). Rest-
ing CD4
 
 
 
 T cells were purified as described previously (33).
Briefly, PBMCs were incubated with anti-CD4 mAbs conju-
gated with Dynabeads (Dynal) for 30 min and the bead-bound
cells were recovered using a magnet (Dynal). The bead-bound
cells were then washed and the CD4
 
 
 
 T cells were detached
from the beads using Detachabead, according to the manufac-
turer’s instructions (Dynal). These cells were then incubated with
anti–HLA-DR and CD14 antibodies (BD Biosciences) followed
by Dynabeads conjugated with goat anti–mouse IgG (Dynal) and
magnetic removal of bead-bound preactivated cells and residual
monocytes or dendritic cells (DCs)
 
*
 
. This purification protocol
typically resulted in 99.5% purity of positively selected cells, as
determined by postpurification FACS
 
®
 
 analysis. In some experi-
ments purified CD4
 
 
 
 T cells were further negatively sorted into
CD45RO
 
 
 
 and CD45RA
 
 
 
 subsets by staining the cells with
anti-CD45RA and anti-CD45RO antibodies (BD Biosciences),
respectively and magnetically removing the stained cells using
goat-anti–mouse IgG beads. V
 
 
 
24
 
 
 
 T cells were purified by in-
cubating PBMCs with V
 
 
 
24 antibody (Coulter), followed by
staining with goat-anti–mouse IgG antibody conjugated with
MACS
 
®
 
 beads (Miltenyi Biotec). Bead-conjugated cells were
then positively sorted using a MACS
 
®
 
 sorter. The culture media
used in all experiments was RPMI 1640 (Life Technologies) sup-
plemented with 10% FCS (Hyclone), penicillin (50 U/ml; Life
Technologies), streptomycin (50 ug/ml), sodium pyruvate (1
 
mM; Life Technologies) and glutamine (2 mM; Life Technolo-
gies) (10% RPMI 1640). All cytokines were purchased from
R&D Systems. DCs were generated as described previously (34).
Briefly, CD14
 
 
 
 monocytes were purified using the MACS
 
®
 
 sys-
tem (Miltenyi Biotec) and cultured in the presence of IL-4 (100
ng/ml) and GM-CSF (50 ng/ml) (both from R&D Systems) for
4–6 d.
 
Study Subjects.
 
Healthy donors were adults negative for HIV-1
and with no history of chronic viral infections such as Hepatitis B
or C. Mean age of healthy donors was 34, 64% were male and
36% were female. Whole blood samples from adults with HIV-1
infection were obtained during routine primary care visits at the
Comprehensive Care Center, Vanderbilt University Medical
Center, Nashville, TN. Mean age of the HIV-1 infected donors
was 40, 74% were male and 26% were female. There were no se-
lection criteria based on race or sex. All subjects provided written
informed consent, and the study was approved by the Vanderbilt
Institutional Review Board.
 
Virus Production and Infections.
 
Vesicular stomatitis virus gly-
coprotein (VSV-G) pseudotyped replication incompetent HIV-1
particles were generated as described previously (33). Briefly,
HEK-293T cells were transfected with 20 
 
 
 
g of proviral HIV-1
vector and 12 
 
 
 
g of pL-VSV-G plasmid per 3 
 
 
 
 10
 
6
 
 cells seeded
on 10-cm plates. Supernatants were collected at 48 h after trans-
fection, centrifuged, and passed through 0.4-
 
 
 
m filters to remove
fine debris and stored at
 
  
 
80
 
 
 
C. The viral titers were determined
by infection of the human T cell line Hut78 with serially diluted
virus supernatant. R5- or X4-tropic replication-competent vi-
ruses were prepared similarly by transfecting 293T cells with
HIV-1 that encodes R5- or X4-tropic (BAL and NL4–3 respec-
tively) envelope and EGFP (CLONTECH) in place of the 
 
nef
 
gene as described previously (33). Typically viral titers ranged
from 0.5–2 
 
 
 
 10
 
6
 
 ifu/ml for replication competent viruses and
5–10 
 
 
 
 10
 
6
 
 for VSV-G pseudotyped HIV-1. Wild-type virus
(NL4–3) with X4-tropic or with R5-tropic envelope (BAL) and
virus (R8) encoding heat stable antigen (HSA) in place of 
 
vpr
 
 (35)
with intact 
 
nef
 
 gene were gifts of Drs. Vineet KewalRamani, Na-
tional Cancer Institute, Frederick, MD, and Chris Aiken,
Vanderbilt University School of Medicine, Nashville, TN, re-
spectively. The titers for the wild-type viruses were determined
using the sensitive GHOST assay as described previously (36).
Viral replication in T cell cultures was determined by either
FACS
 
®
 
 analysis using GHOST assay or by measuring p24 levels
within supernatants by an ELISA.
 
Detection of NKT Cells by CD1d-Tetramers.
 
Tetramers of
mouse CD1d were produced by streptavidin-mediated tetramer-
ization of folded CD1d1-
 
 
 
2m heterodimers which will be de-
scribed in detail elsewhere (unpublished data). Briefly, mouse
CD1d and human 
 
 
 
2m were expressed in Drosophila cells (S2;
Invitrogen). CD1d1-
 
 
 
2m complexes were purified by metal af-
finity chromatography and biotinylated using biotin protein ligase
(Avidity). Free biotin was removed by dialysis, and biotinylation
efficiency was ascertained with a colorimetric assay using avidin
peroxidase (Sigma-Aldrich). CD1d1 was loaded with ligand by
incubating monomers with a threefold molar excess of 
 
 
 
-GalCer
(obtained from Kirin Brewery Co., Japan) for 12–16 h at room
temperature. Tetramers for flow cytometry were prepared by
mixing monomers with streptavidin-allophycocyanin (Molecular
Probes) at a molar ratio of 4:1. Staining was performed by incu-
bating cells on ice for 30 min at a concentration of 10 
 
 
 
g/ml.
 
Flow Cytometry.
 
Cells were stained with the relevant anti-
body on ice for 30 min in PBS buffer with 2% FCS and 0.1% So-
dium azide, washed twice, fixed with 1% paraformaldehyde, and
 
*
 
Abbreviations used in this paper:
 
 
 
 
 
-GalCer, 
 
 
 
-galactosylceramide; DC, den-
dritic cell; GFP, green fluorescent protein; HSA, heat stable antigen; MOI,
multiplicity of infection; VSV-G, vesicular stomatitis virus glycoprotein. 
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analyzed with a FACSCalibur™ four-color cytometer, using the
CELLQuest™ program. Live cells were gated based on forward
and side scatter properties. The following anti–human antibodies
were used in stainings: CD3, CD4, CD8, CD11b, CD25,
CD45RO, CD45RA, HLA-DR, CD161, (all from BD Bio-
sciences), and V
 
 
 
24, V
 
 
 
11 (Coulter), antibodies to chemokine
receptors CCR1, CCR3, CCR5, CXCR4, CXCR6 (R&D Sys-
tems), CCR7 and CXCR3 (BD Biosciences). Anti–mouse HSA
(CD24) was purchased from BD PharMingen. Cytokines in the
culture supernatant were measured using Cytometric Bead assay
(CBA) by flow cytometry, according to the manufacturer’s (BD
Biosciences) instructions. Cell death was assessed by staining the
cells with propidium iodide.
 
Statistical Analyses.
 
Continuous variables were compared by
Mann-Whitney U test, or by determining Pearson correlation
coefficients. Linear regression analysis used an entry method, with
entry and removal criteria of 0.05 and 0.01, respectively. All sig-
nificance levels were based on Student’s two-tailed tests. Statisti-
cal analyses were performed using SPSS version 9.0.
 
Results
 
Isolation, Expansion, and Phenotypic Characterization of
V
 
 
 
24
 
 
 
 NKT cells.
 
To expand NKT cells ex vivo in
short-term cultures, V
 
 
 
24
 
 
 
 T cells were first enriched by
magnetic cell sorting from PBMCs of healthy individuals.
We found that 20–80% of purified V
 
 
 
24
 
 
 
 T cells also ex-
pressed V
 
 
 
11, suggesting that these cells were of the NKT
cell lineage (data not shown). Purified V
 
 
 
24
 
 
 
 T cells were
then stimulated with autologous DCs) pulsed with 
 
 
 
-Gal-
Cer and expanded in IL-2 for 1–2 wk. In parallel, conven-
tional CD4
 
 
 
 T cells were purified from the same individual
and activated with Staphylococcus enterotoxin B (SEB)-
pulsed DCs, which were expanded and maintained in IL-2.
After 10 d of culture, all of the 
 
 
 
-GalCer–stimulated V
 
 
 
24
T cells also expressed V
 
 
 
11, whereas V
 
 
 
24
 
 
 
V
 
 
 
11
 
 
 
 T cells
were virtually undetectable among the SEB stimulated T
cell cultures (Fig. 1 A). To determine whether V
 
 
 
24
 
 
 
V
 
 
 
11
 
 
 
 T cells belong to the NKT cell lineage, ex vivo ex-
panded T cell lines were stained with CD1d 
 
 
 
-GalCer tet-
ramers (henceforth, CD1d-tetramers) which selectively
bind with V
 
 
 
24-J
 
 
 
18 NKT cells. All of the V
 
 
 
11
 
 
 
 T cells
in 
 
 
 
-GalCer–stimulated cultures also stained with the
CD1d-tetramer, demonstrating that these cells express
NKT cell–specific receptors (Fig. 1 A). Further, a portion
of the NKT cell lines coexpressed CD161 characteristic of
NK cells, whereas SEB-stimulated CD4
 
 
 
 T cell lines were
negative for these markers (Fig. 1 B). A sizeable portion of
in vitro derived NKT cells also expressed CD4 (Fig. 1 B),
which varied between 20–60% of total cells (of 22 healthy
donors analyzed, data not shown), and a smaller subset of
the NKT cells were CD8
 
 
 
 or CD4
 
 
 
CD8
 
 
 
 (Fig. 1 B).
 
Chemokine Receptor Expression and Cytokine Production by
Activated NKT Cells.
 
HIV-1 entry into cells requires, in
addition to CD4, one of the coreceptors CCR5 or CXCR4
(26). Little is known about the chemokine receptor/HIV
coreceptor expression patterns of NKT cells. Therefore, ac-
tivated NKT and CD4
 
 
 
 T cells were stained with mAbs di-
rected against various chemokine receptors. We found that
almost all of the NKT cells expressed very high levels of
CCR5 and most were also positive for CXCR6 and
CXCR3 (Fig. 2 A). Remarkably, the expression levels of
these chemokine receptors on NKT cells were much higher
than those on SEB stimulated CD4
 
  T cells (Fig. 2 A and
B). In contrast, expression of the T-tropic HIV-1 corecep-
tor CXCR4 was lower on NKT cells than on CD4  T
cells. Of interest, chemokine receptor CCR7 was expressed
by very few NKT cells (Fig. 2 A). CCR3 was not expressed
by either type of T cells (data not shown). This chemokine
receptor expression profile of NKT cells is consistent with
that of conventional effector/memory T cells (37). Similar
expression patterns were observed in three other indepen-
dently derived NKT cell cultures from three different
healthy individuals (data not shown).
To assess the effector function of NKT cells isolated in
this manner, we determined their cytokine secretion pat-
terns. NKT cells were restimulated with  -GalCer–pulsed
DCs and compared with a conventional T cell line stimu-
lated with SEB-pulsed DCs. Cytokine levels in superna-
tants were quantitated using CBA assay (38). Activated
NKT cells secreted distinctive and copious amounts of
IL-4, IL-5, IFN- , and TNF-  (data not shown) as has
been reported (15, 39).
Expression of Chemokine Receptors on Resting NKT
Cells. Our in vitro–derived NKT cell lines express high
levels of CCR5 and CXCR6 (Fig. 2). To exclude the pos-
Figure 1. Phenotype of in vitro–expanded NKT
cells. Purified CD4  T cells were activated by SEB
(100 ng/ml) and purified V 24  T cells were stimu-
lated with  -GalCer (100 ng/ml) in the presence of
autologous DCs. Cells were expanded in IL-2 for 14 d.
(A) To determine expansion of NKT cells in vitro–
expanded T cell lines were stained with anti-V 11-PE,
anti-V 24-FITC, and CD1d-tetramer-APC. (B) Ex-
pression of CD4, CD8, and NK markers on SEB-stim-
ulated CD4  or  -GalCer-stimulated NKT cell lines.
Cells were costained with anti-CD4-PercP and anti-
CD8-FITC, and individually stained with purified anti-
CD161 followed by FITC-conjugated anti–mouse IgG.872 Infection of NK T Cells by HIV-1
sibility that the expression of these chemokine receptors re-
sulted from in vitro activation or cell culture in the pres-
ence of IL-2, the expression levels of CCR5 and CXCR6
were examined on resting NKT cells. For these studies we
employed a four-color FACS® protocol. Freshly derived
PBMCs were stained with NKT cell–specific TCR (anti-
V 24 and anti-V 11 or CD1d-tetramer) and anti-CD3
antibodies in combination with various cell surface markers
(Fig. 3). As shown in Fig. 3,  50% of NKT cells express
CD4 and a small subset expresses CD8, but at lower levels
than conventional CD8  T cells (Fig. 3). In addition all
NKT cells express the memory T cell marker CD45RO
and the majority of these cells also express CD161 (Fig. 3).
Importantly, like in vitro–expanded NKT cells, resting
NKT cells express high levels of CCR5 and CXCR6 but
lower levels of CCR7 (Fig. 3). NKT cells also expressed
CXCR4 at lower levels than conventional T cells (Fig. 3),
and some donors also expressed high levels of CCR1 and
CXCR3 (data not shown). These data demonstrate that
our in vitro expanded NKT cells recapitulate the pheno-
type of resting NKT cells freshly derived from PBMCs.
HIV-1 Infects CD4  NKT Cells. High expression lev-
els of HIV-1 coreceptors CCR5 and CD4 on a subset of
NKT cells prompted us to determine whether these cells
are susceptible to HIV-1 infection. Because NKT cell cul-
tures contain both CD4  and CD4  cells, in some experi-
ments NKT cells were purified into CD4  and CD4 
subsets. Both NKT and conventional T cell lines were in-
fected, at varying multiplicity of infection (MOI), with
green fluorescent protein (GFP) encoding replication-
competent HIV-1 strains, which use CCR5 (R5-tropic)
or CXCR4 (X4-tropic) as coreceptors for entry. As a con-
trol, cells were infected with replication-defective HIV-1
pseudotyped with VSV-G envelope that bypasses receptor
Figure 2. Expression of chemo-
kine receptors on in vitro–activated
NKT cells. T cell lines were ex-
panded as described in the legend of
Fig. 1 and stained with chemokine
receptor antibodies followed by
PE-conjugated anti–mouse IgG. (A)
 -GalCer–stimulated NKT cells.
(B) SEB-stimulated CD4  T cells.
Figure 3. Phenotype of resting NKT cells in PBMCs. PBMCs from healthy donors were first stained with anti-V 11-PE, anti-CD3-PercP.Cy5.5, and
either anti-V 24-FITC or CD1d-tetramer-APC in combination with anti-CD4-APC, and anti-CD8-PE. To stain with mAbs directed against CD161,
CD45RO, and chemokine receptors, CCR5, CXCR6, CCR7, CXCR4, cells were first incubated with purified antibodies, followed by second step
staining with anti–mouse IgG-APC. After extensive washing cells were preincubated with mouse Ig to neutralize any free anti–mouse Ig. Cells were then
stained with anti-V 11-PE, V 24-FITC, and CD3-PercP-Cy5.5. Electronic gates were set on CD3  V 24 V 11  or CD3 V 11 CD1d-tetramer  T
cells or V 24 V 11  cells to analyze expression of molecules, listed above, on NKT and conventional T cells, respectively. For CXCR4 expression,
mean intensity of fluorescence is shown.873 Motsinger et al.
requirements for viral entry. We found that CD4  NKT
cells were highly susceptible to HIV-1 infection with R5-
tropic strains (Fig. 4 A). After 3 d of infection, with R5-
tropic viruses at MOI of 1,  50% of the CD4  NKT cells
and 4–5% of conventional CD4  T cells were infected
(Fig. 4 A). In contrast, conventional CD4  T cells were
approximately twice as susceptible than CD4  NKT cells
to infection with an X4-tropic virus (Fig. 4 A). CD4 
NKT cells were resistant to infection by both R5- and
X4-tropic viruses (Fig. 4 A). Although, both viruses lack
nef gene, a significant fraction of the infected T cells
downregulated CD4 (Fig. 4 A), possibly due to interaction
with HIV-1 envelope glycoprotein and presence of the ac-
cessory protein Vpu (40, 41). CD4  and CD4  NKT cells
as well as conventional CD4  T cells were equally suscep-
tible to infection by VSV-G pseudotyped HIV-1 (Fig. 4
A), suggesting that dramatic differences in infectivity of
NKT cells and conventional T cells by R5-tropic viruses
are caused by differential receptor-mediated viral entry.
Because the viruses used in these experiments lacked a
functional  nef gene due to replacement with GFP, we
sought to determine whether presence of Nef effects the
infectivity of NKT cells. NKT cells and conventional
SEB-stimulated CD4  T cells were infected with virus
strains engineered to express the murine HSA antigen sur-
face marker in place of vpr gene (35, 42). These viruses ex-
press Nef and were shown to fully replicate in an in vivo
model of HIV-1 infection (42). Similar to nef-deleted GFP
expressing viruses, nef  strains infected NKT cells and
spread in these cultures at a rate higher than SEB-stimu-
lated CD4  T cells (Fig. 4 B).
To determine whether resting NKT cells can also be in-
fected, PBMCs were directly infected with GFP- or HSA-
expressing viruses. To assess the role of cytokines in the in-
fection of resting NKT cells, PBMCs were also stimulated
with either IL-2 or IL-15 for 1 d and infected for 3 more d.
As expected infection of resting T cells was much less ro-
bust than TCR-stimulated cells (Fig. 5 A). However, the
proportion of resting CD4  NKT cells that were GFP pos-
itive was consistently higher ( 3–5-fold) than conven-
tional resting CD4  T cells (Fig. 5 B). Short-term stimula-
tion of the cultures with IL-15 or IL-2 showed a slight
increase in the percentage of infected CD4  NKT and
conventional CD4  T cells (Fig. 5 B). We next sought to
compare the infection of freshly isolated NKT cells vis a vis
with CD4  memory or CD4  naive T cells, activated
through the TCR. For this experiment we first purified
CD4  T cells which were further sorted into V 24  T
cells, CD45RO  memory, or CD45RA  naive T cells.
The V 24 CD4  T cells were then stimulated with
 -GalCer plus DCs and CD4 RA  or RO  conventional
T cells were stimulated with SEB plus DCs. All three sets
of T cells were also infected with GFP expressing R5-
tropic viruses. At third day of infection T cells were stained
with CD1d-tetramers and V 11, to identify NKT cells,
with CD25 to gate on TCR-activated T cells, (since SEB
only activates a portion of T cells) and CD11b to exclude
any remaining DCs. As shown in Fig. 5 C, TCR-stimu-
lated resting NKT cells were infected substantially more
than both TCR-activated memory or naive CD4  T cells.
These results reinforce our finding that CD4  NKT cells
are infectable with R5-tropic viruses at a higher rate than
conventional CD4  T cells and may be targeted by HIV-1
in vivo. Further, low level infection of resting NKT cells
suggest, similar to conventional T cells, antigen-stimulation
of NKT cells greatly enhances their susceptibility to HIV-1
infection (Fig. 5).
Replication of HIV-1 in NKT Cells. We next moni-
tored the replication of HIV-1 within the NKT and con-
ventional T cell cultures. NKT cells and conventional T
cells were infected at a low MOI of 0.01, and GFP expres-
sion by infected cells was assessed at different time points
after infection. The R5-tropic virus very rapidly spread in
NKT cell cultures (Fig. 6 A). Indeed, infected CD4 
NKT cells, as assessed by GFP expression, increased by
Figure 4. Infection of NKT cells by HIV-1. SEB-stimulated CD4  T
cells and  -GalCer stimulated NKT cell cultures were described in Fig. 1
legend. Activated NKT cells were further sorted into CD4  and CD4 
subsets. At days 7–10 after activation cells were infected with: (A) GFP-
encoding R5-tropic, X4-tropic viruses, or VSV-G pseudotyped HIV
vector at MOI of 1. After 3 d, cells were stained with anti-CD4-PE, fixed
with 2% paraformaldehyde, and GFP expression was analyzed by FACS®.
(B) Cells were also infected with HSA-encoding nef  R5-tropic viruses at
MOI 1 and 0.01. After 3 and 5 d after infection, cells were stained with
FITC-conjugated anti–mouse HSA, fixed with 2% paraformaldehyde,
and HSA expression was analyzed by FACS®.874 Infection of NK T Cells by HIV-1
 15-fold from 4 to 60% of the cells between days 3 and 6
(Fig. 6 A), similar to infection with nef  HSA expressing
viruses (Fig. 4 B). In contrast, X4-infected NKT cell cul-
tures contained a constant number of GFP  cells (between
1 and 2%) up to 12 d after infection (Fig. 6 A, and data not
shown). As expected, R5- and X4-tropic viruses replicated
in conventional CD4  T cell cultures, albeit at slower ki-
netics compared with NKT cells (Figs. 4 B and 6 A). The
production of virus by infected cultures were also deter-
mined, at different time points, by quantitating HIV p24
antigen and infectious virus in the culture supernatants us-
ing ELISA and GHOST assays, respectively. Both wild-
type nef  and nef  viruses rapidly replicated in NKT cells,
as assessed by p24 levels in the supernatants (Fig. 6 B). At
days four and six after infection, NKT cultures contained
10–20-fold more viral particles compared with SEB-stim-
ulated CD4  T cells (Fig. 6 B). To determine whether the
virus produced from NKT cells was infectious, we used
highly sensitive GHOST assay, which turns on GFP ex-
pression (through Tat protein) when infected with HIV-1
(36). At each time point after infection, NKT cells pro-
duced   10-fold more infectious virus than SEB-stimu-
lated T cells and with replication kinetics that paralleled
p24 levels (data not shown).
To assess whether HIV-1 induces cell death, we infected
a NKT cell culture, containing  50% CD4  cells, either
with R5-tropic or X4-tropic viruses. The percentage of
CD4  and dead cells within the postinfection cultures were
determined by FACS® analysis. 12 d after infection no
CD4  NKT cells were detectable, even in cultures infected
at an MOI as low as 0.01. At high MOI (0.3–1) most
CD4  NKT cells were depleted by day 6 after infection
(Fig. 6 C). In stark contrast, in cultures infected with X4-
tropic viruses, the proportion of CD4  NKT cells re-
mained similar to uninfected or VSV-G virus infected cul-
tures (Fig. 6 C, and data not shown). Although, significant
cell death was also observed in conventional T cell cultures
following infection with both R5- and X4-tropic viruses,
at least 50% of these cells were viable after 6 d after infec-
tion even at high MOI levels (data not shown). Thus, the
R5-tropic virus rapidly replicates and depletes the CD4 
NKT cell subset with faster kinetics compared with con-
ventional CD4  T cells.
Analysis of NKT Cells in HIV-1 Infected Individuals. Be-
cause NKT cell lines are efficient hosts for HIV-1 in vitro
and because resting NKT cells express similar levels of
CCR5, we concluded that HIV-1 can infect NKT cells in
vivo. To gain insight into the role of NKT cells during nat-
ural HIV-1 infection, we quantified NKT cell numbers
both in HIV-1 infected and healthy individuals. PBMCs
were isolated from infected or healthy donors and cells
were subjected to four-color FACS® analysis using anti-
V 11, CD3, and CD4 mAbs in conjunction with either
CD1d-tetramer or V 24-specific antibodies. CD4  or
CD4  NKT cells were identified in 48 HIV-1 infected
adults. Ages ranged from 34 to 59 y, 33% were African-
American, 25% were female, 83% were receiving antiretro-
viral therapy, and the mean CD4  T cell counts was 402
cells/mm3 (range 8 to 1,080 cells/mm3). 10 (21%) had se-
rologic evidence of either hepatitis B or C virus infection.
None had active cytomegalovirus disease. As controls 22
uninfected healthy individuals were studied. The HIV-
infected patients were slightly older than uninfected patients
(mean age 40 versus 34 y; P   0.011). The groups did not
Figure 5. HIV-1 infection of resting or cytokine stimulated NKT cells
in PBMCs. PBMCs were isolated and incubated for one day either in
media alone or in the presence of IL-2 (50 U/ml) or IL-15 (10 ng/ml).
Cells were then infected with R5-tropic virus expressing GFP or HSA.
After 3 d of infection PBMCs were stained with CD3-PercP.Cy5.5,
V 11-PE, and V 24-biotin followed by strepavidin-APC. Cells that were
infected with HSA-expressing viruses were also stained with HSA-FITC.
(A) Approximately 10 million events were acquired for each sample to ob-
tain statistically significant number of infected NKT cells. NKT cells were
identified by gating on CD3 V 24  cells and staining for V 11 (top),
conventional T cells were gated on CD3 V 24  cells (bottom). To facil-
itate visual comparison, only 1% of events acquired is shown for conven-
tional T cells (bottom). (B) Cells were also stained with CD4-Percp,
V 11-PE, and V 24-biotin followed by strepavidin-APC to determine
the percent of CD4  NKT and conventional T cells that are infected
with HIV-1. (C) Purified CD4 V 24  (NKT), CD4 CD45RO 
(memory T), CD4 CD45RA  (naive T), were stimulated through TCR
and infected with R5-tropic HIV-1 expressing GFP. At 3 d after infec-
tion cells were stained with CD1d-tetramer-APC, CD25-PE (RA  or
RO  T cells), or with V 11-PE (V 24  T cells) and CD11b-Cy. Elec-
tronic gates were set on CD25 CD11b  (for RO   and RA ) or
V 11 CD11b  (for V 24 ) T cells and on large cell size.875 Motsinger et al.
differ with regard to gender (P   0.05). Approximately
44% of HIV-infected donors had undetectable levels of
NKT cells (our detection limit was 0.003%), whereas all of
the healthy donors had at least 0.01% NKT cells within
their PBMCs (P    0.001) (Fig. 7 A). In fact, 81% of
healthy donors contained  0.01% NKT cells and 19% of
these donors had  0.1% NKT cells (Fig. 7 A). Only  30%
of HIV-1–infected individuals had  0.01% NKT cells and
none had  0.1% (Fig. 7 A).
Characterization of samples from HIV-infected subjects
by univariate analysis showed that plasma HIV-1 RNA
concentration was inversely correlated with CD4  T cell
count (r     0.561,  P    0.001) and percentage (r  
 0.631, P   0.001), CD4  NKT cell percentage (r  
 0.548, P   0.006) (Fig. 7 C), but not with total NKT
cell percentage (r   0.194, P   0.05) (Fig. 7 B). Although
six subjects were not receiving antiretroviral therapy, nei-
ther CD4  NKT cell nor total NKT cell percentages dif-
fered depending on whether antiretroviral therapy was be-
ing prescribed (P   0.05). Mean NKT cell percentage of
Figure 6. HIV-1 replication in NKT cell lines. (A) CD4  and NKT
cell lines were infected with R5-tropic, X4-tropic or VSV-G pseudo-
typed HIV-1 at varying MOI (0.01–1). After 2, 3, and 6 d of infection
cells were stained with anti-CD4-PE, fixed and analyzed by FACS®. The
percentage of GFP  cells in the cultures is shown. (B) Supernatants from
NKT cell cultures, infected with wild-type nef , or nef  virus MOI of
0.002 (p24:  200pg/ml), were collected at different time points and HIV
p24 levels were measured by ELISA. (C) Numbers of CD4  NKT cells
were monitored in unsorted NKT cell lines at 2, 3, 6, and 12 d after in-
fection by staining with anti-CD4-PE.
Figure 7. Analysis of NKT cells in HIV-1 infected and healthy donors.
PBMCs from healthy and HIV-infected donors were isolated and stained
with anti-V 11-FITC, CD3-PercP.Cy5.5, CD4-PE, and CD1d-tet-
ramer-APC. Alternatively, cells were stained with anti-V 11-PE, V 24-
FITC, CD3-PercP.Cy5.5, and CD4-APC. Electronic gates were set on
CD3 V 11 V 24  or CD3 V 11 CD1d-tetramer  cells to identify
the NKT cell subset. Between 3 and 5 million events were collected for
each sample. Analysis was performed on CD3-gated T cells. The sensitiv-
ity for detecting NKT cells was at least 0.003%. (A) Portion of NKT cells
among CD3  T cells of 48 HIV-infected (left) and 22 HIV-negative sub-
jects (right). (B) Relationships between NKT cell percentage, plasma
HIV-1 RNA concentration, and CD4  T cell counts in HIV-1–infected
individuals. CD4  T cells were  200 cells/mm3 (white circles), 200–500
cells/mm3 (black circles), or  500 cells/mm3 (white squares). (C) Rela-
tionship between CD4  NKT cell percentage and plasma HIV-1 RNA
concentration in HIV-1–infected subjects. The regression line is shown.876 Infection of NK T Cells by HIV-1
HIV-infected untreated individuals was about sixfold lower
(0.038%) compared with healthy donors (0.26%) but this
difference was not statistically significant, possibly due to
the relatively few patients with untreated HIV infection
(P   0.05). To exclude any effects of possible chronic viral
infections on NKT cell percentages, we compared the 10
hepatitis seropositive and 38 hepatitis seronegative HIV-
infected patients with healthy donors. NKT cell percent-
ages were greatly reduced in both groups which was highly
statistically significant (P   0.001 for each comparison).
This analysis indicates that differences in NKT cell percent-
age are not due to hepatitis virus coinfection. When data
from HIV-infected subjects was analyzed by linear regres-
sion, only CD4  NKT cell percentage was significantly
correlated with plasma HIV-1 RNA concentration (P  
0.011). These results demonstrate both a severe reduction
in NKT cells and selective loss of the CD4  NKT subset
during HIV-1 infection.
Discussion
We have shown that human NKT cells, resting or acti-
vated, express high levels of chemokine receptors, includ-
ing HIV-1/SIV coreceptors CCR5 and CXCR6, and that
they are highly susceptible to infection with R5-tropic
strains of HIV-1. The chemokine receptor family is differ-
entially expressed on naive and memory subsets of human
T cells. CC family chemokine receptors, including CCR5,
CCR6, CXCR3, and CXCR6 are expressed primarily on
the CD45RO  or CD26  memory/activated subset of T
cells (43–46), whereas CXCR4 and CCR7 are expressed at
higher levels on naive T cells. The memory/effector phe-
notype of NKT cells, in vitro and in vivo, is consistent
with this expression pattern. Recently, human memory T
cells were further subdivided, based on CCR7 expression,
into two functionally distinct subsets (47). CCR7  mem-
ory cells lack the lymph node homing receptor, CD62L,
express receptors for migration to inflamed tissues and
display immediate effector function (47, 48). In contrast,
CCR7  memory cells express lymph node homing re-
ceptors and lack immediate effector function. Of interest,
the CCR7  cells are also enriched for expression of
CCR5 (47, 49) and CCR5 CXCR6  cells predominate
in extralymphoid tissues (50). The patterns of chemokine
receptor expression on resting or activated NKT cells de-
scribed here, CCR7 CCR5 CXCR6 , are consistent
with a phenotype of memory T cells that would be com-
partmentalized to the organs and/or mucosal tissues
where these cells are likely to be exposed to pathogens in-
cluding HIV-1.
High expression levels of CCR5 and CD4 on NKT cells
prompted us to determine their susceptibility to HIV-1 in-
fection. Remarkably, we found that both activated and
resting CD4  NKT cells are more susceptible to infection
with R5-tropic, but not X4-tropic, viruses relative to con-
ventional CD4  T cells. These findings suggest that NKT
cells play a key role in establishing infection given their
perpetually activated state. Cell surface expression of
CCR5 is critical in transmission of HIV-1 infection. Indi-
viduals bearing a homozygous 32-base pair deletion in the
CCR5 gene that prevents CCR5 expression are largely re-
sistant to HIV-1 infection (51–53). This compelling obser-
vation argues strongly that entry of R5-tropic strains into
susceptible target cells is requisite for the establishment of
HIV-1 infection. Why the absence of one HIV-1 corecep-
tor confers resistance remains unclear since these individu-
als have intact CXCR4 receptors and most are resistant to
infection, despite exposure to both R5- and X4-tropic vi-
ruses (54, 55). Based on our results we speculate that NKT
cells may be targeted at the initial phases of infection be-
cause of their high susceptibility to R5-tropic viruses and
effector/memory status at sites where HIV-1 gains entry.
Possibly the interaction between HIV-1 infected DCs and
NKT cells facilitates infection through signaling NKT cells
with endogenous ligand(s) and cytokines.
Our findings also show that NKT cells in PBMCs of
HIV-1–infected individuals are dramatically reduced as
compared with healthy donors. Although disappearance of
the CD4  NKT cell subset is consistent with rapid replica-
tion and cell death upon infection with R5-tropic viruses
(Fig. 6), it is not clear why CD4  NKT cells also disappear
in HIV-1–infected individuals. It has been reported that
NKT cells are reduced in numbers in several pathologic
conditions such as autoimmune diseases (56–60) and during
bacterial (61) and viral (62) infections. Current evidence
suggests that in vivo activation of NKT cells through TCR
ligation, results in rapid loss of these cells by apoptosis. This
activation induced cell death is dependent on DC-derived
IL-12 (63). Therefore, it is possible that during HIV-1 in-
fection, NKT cells are activated by direct (antigen) or indi-
rect mechanisms (cytokines), which result in activation in-
duced cell death. However, after their initial disappearance,
NKT cells usually rapidly reappear in vivo whereas during
HIV-1 infection there may be either chronic stimulation or
loss of NKT precursors, leading to a more permanent de-
fect. It remains to be determined whether NKT cells reap-
pear and fluctuate during the course of HIV-1 infection. As
an alternative scenario, it is also possible that reduced num-
bers of CD4  NKT cells in HIV  individuals are due to ex-
pression of CD4 on these cells at some point during their
differentiation and thus rendering them susceptible to in-
fection. It will be important to understand whether any of
these mechanisms play a role in the reduction of NKT cells
during HIV-1 infection.
It will also be important to determine whether loss of
NKT cells during HIV-1 infection affects the course of the
disease. Recently, NKT cells have been implicated in the
regulation of autoimmune diseases through suppression of
immune responses against autoantigens (64) and antigens
exposed in immune privileged sites (65). Indeed, in murine
models of diabetes, stimulation of NKT cells can protect
susceptible animals from the disease (66, 67). It has been
proposed that NKT cells may also facilitate responses dur-
ing bacterial (25) and viral infections (24, 68). Therefore, it
is possible that NKT cells have a beneficial role in protect-
ing against HIV-1 infection through secretion of chemo-877 Motsinger et al.
kines or other effector functions. It is also possible that
NKT cells affect the course of disease through secretion of
large amounts of cytokines. Indeed, NKT cells activated
by  -GalCer induce extensive bystander proliferation of
memory T cells in the spleen and liver through cytokine
production (20, 69, 70). During HIV-1 infection, cytokine
production from activated NKT cells may recruit bystander
resting T cells and render them susceptible to HIV-1 infec-
tion (33). Further examination of both in vitro and animal
models for HIV-1 infection, particularly SIV infection of
macaques, may yield insights toward the roles these cells
play in viral replication and pathogenesis.
In conclusion, our findings implicate an important role
for NKT cells in HIV-1 infection defining them as a sec-
ond subset of T cells that undergoes depletion as a result of
viral infection. It will be critical to determine at what level
NKT cells affect the transmission and propagation of HIV-1
in vivo and how they contribute to the complex pathogen-
esis underlying AIDS.
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